[Clinical tests of a new corticoid for topical use: Nerisona].
作者信息
Yañez de Mena E
出版信息
Z Hautkr. 1976;51 Suppl 1:37-9.
PMID:795186
Abstract
Diflucortolone valerate 0.1% (Nerisona), a new topical corticoid, was clinically investigated in ointment form in 51 patients suffering from neither weeping nor very dry allergic and inflammatory skin diseases. The results obtained were good, improvement being observed in 92.1% of the treated cases. The cosmetic properties of the preparation were excellent. No local or systemic side effects were observed.
摘要
相似文献
1
[Clinical tests of a new corticoid for topical use: Nerisona].
Z Hautkr. 1976;51 Suppl 1:37-9.
2
[Clinical tests with Nerisona cream (SH K 183 MB)].
Z Hautkr. 1976;51 Suppl 1:56-9.
3
[Difluocortolone valerate in dermatology].
Z Hautkr. 1976;51 Suppl 1:20-2.
4
[Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
Z Hautkr. 1976;51 Suppl 1:1-16.
5
[Difluocortolone valerate: a new corticoid for topical use].
Z Hautkr. 1976;51 Suppl 1:23-6.
6
[Clinical tests of the therapeutic effect of a new difluocortolone valerate cream].
Z Hautkr. 1976;51 Suppl 1:33-6.
7
[Treatment of inflammatory dermatoses with difluocortolone valerate].
Z Hautkr. 1976;51 Suppl 1:40-2.
8
[The use of difluocortolone valerate for various dermatoses].
Z Hautkr. 1976;51 Suppl 1:60-1.
9
[Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
Z Hautkr. 1976;51 Suppl 1:27-9.
10
[Evaluation of a new corticoid for various dermatoses].
Z Hautkr. 1976;51 Suppl 1:43-6.
Zotero 插件